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ABSTRACT
In this study, multiple models from Atmospheric Chemistry and Climate Model
Intercomparison Project (ACCMIP) are utilized to derive the global burden of disease of
chronic obstructive pulmonary disease (COPD), lung cancer (LNC), and lower
respiratory infection (LRI) derived from surface PM2.5 elevation. Various Representative
Concentration Pathways and Shared Socio-economic Pathways scenarios are
compared as well as various models to deduct the impact from various scenarios. The
time series variation and seasonal variation are also illustrated in this study. Multi-model
ensemble was conducted to reduce the deviation in model projection output.
Projection shows increase in the population normalized relative risk for COPD, LNC,
and LRI disease between 2030 and 2000 for developed countries and northern Africa
for various population scenarios using the average value for different emission
scenarios from GISS-E2-R model output. MIROC-CHEM actually predicts a much lower
normalized PM concentration or relative risk level than GISS-E2-R model. Black carbon
adjusted relative risk results show that LNC derived relative risk might be much more
sensitive for black carbon compared with COPD or LRI. LAC region is more sensitive to
black carbon surface pollution compared with other regions for LRI relative risk.
Dust storms in the Saharan regions can be a major contribution to risk elevation in
Saharan and adjacent regions. Australia dust storm in the central Australia can also be
responsible to the exposure at coastal areas. The emission increase in East Asia since
1980s can be responsible to the widespread risk elevation in recent years.
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CHAPTER ONE
INTRODUCTION AND GENERAL INFORMATION
1.1 PM2.5 POLLUTION DEFINITION
PM2.5 is defined as air pollutants with a diameter of 2.5 micrometers or less. The small
sizes makes PM2.5 penetrable and able to invade even the smallest airways of
respiratory systems so as to cause related health impact among human beings.
The ground level PM2.5 concentration has increased since preindustrial times along with
the severity of PM2.5 pollution in the current era due to the anthological emissions
associated with population growth and excessive emission from human activities.

1.3 PM2.5 AND ITS RELATED HEALTH IMPACT
In recent years, PM2.5 has been found to be associated with a large variety of health
problems including premature mortality. EPA standards suggest that PM2.5 should be
controlled under 12 𝜇𝑔/𝑚3 annually and 35 𝜇𝑔/𝑚3 daily to avoid adverse health impact.
However, adverse health impact has been found to be associated with fine particulate
pollution even with pollution level lower than the EPA suggestion level. (Shi et al., 2015)
PM2.5 has been found to be linked to 3.3 million annual premature mortality over a global
range in 2010. (Lelieveld et. al., 2015)
In our study, the global burden of disease (GBD) assessment is applied to address the
premature mortality derived from global PM2.5 model data and the adverse health impact
is assumed to be only associated with the mass concentration of PM2.5 as source effect
is not considered. Such assumptions can be seen as plausible for GBD studies as in
Burnett’s study, the mass concentration is the main factor taken into consideration. To
further address such problems, the black carbon (BC) data might be regarded as an
additional indicator of health impact to adjust the toxicity of fine particles according to
Janssen’s study. (Janssen et al., 2011)
Primarily short term health impact is vastly examined and discussed from case studies
or cohort studies. Linkage between PM2.5 exposure and acute diseases is verified in
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many studies. For example, Ischemic heart disease (IHD) was found to be associated
with short-term exposure to fine particulates. (Pope et al., 2006) BenMAP-CE is a tool
developed and promoted by US-EPA to calculate the air pollution related acute health
impact over the terrain of US and China by selected C-R functions from various
references.
Compared with PM10(particles with diameter smaller than 10 micrometer) or TSP(total
suspend particle), PM2.5 is a good indicator of health impact since the fine particles are
more penetrable to lung cells and enter bloodstreams compared with coarser particles.
In a cohort study in Shanghai, particles with diameter ranging from 2.5 to 10 µm, health
impact is attenuated and less precise while PM2.5 is statistically significant in adverse
health impact. (Kan et al., 2007)

1.4CLIMATE CHANGE AND EMISSION RELATED PM2.5 CAUSED
HEALTH IMPACT
The severity of PM2.5 in current years has been recognized and emphasized by multiple
studies and with interests in addressing the future PM2.5 induced adverse health impact,
especially premature mortality, to examine how far climate change alone would bring us
regarding this problem.
The Atmospheric Chemistry and Climate Model Intercomparison Project (ACCMIP)
utilizes the new observation added to atmospheric chemistry to optimize the simulations
of tropospheric ozone and aerosols. The modeled data from ACCMIP is used to
calculate the PM2.5 mass concentration derived relative risk and premature mortality
from pre-industrial time to the future era.

1.41ACCMIP MODELS
GFDL-AM3 is utilized to examine the PM2.5 concentration related health impact from
1850 to 2000 in Fang’s study and it is found that the PM2.5 concentration change during
industrial period is mainly caused by changes in direct emission. (Fang et. al., 2013)
GISS-E2-R is utilized to analyze the future PM2.5 variation compared with baseline
including pre-industrial time and present day in the Beijing-Tianjin-Hebei (Jing-Jin-Ji)
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area with four different emission scenarios. (Jie et. al., 2016) Among ACCMIP models,
NCAR-CAM5.1 and GISS-E2-R-TOMAS have the most extensive description of
aerosols compared with other models that can be used in this study. GISS-E2-R
includes the data from 1850 to 2100 for each year, so it is the most continuous data
from the model in ACCMIP. This advantage helps to assist in the studies of Jing-jin-ji
area concentration projection.
The number of aerosol particle as well as the mass of each component are represented
by internally-mixed log-normal modes in NCAR- CAM5.1. While aerosol is represented
by 108 size-resolved aerosol tracers plus three bulk aerosol-phase tracers in 12-size
bins ranging from 10nm to 10µm in dry diameter in GISS-E2-R. The LMDzORINCA
model simulates the distribution of aerosols by superposition of log-normal modes. All
other models use the bulk approach to calculate PM2.5. (Lamarque et al., 2013)

1.42 Chronic health impact
Long-term exposure has also been proved to cause health impact when short-term
health impact is excluded from a case study in the Schwartz’s study. (Schwartz, 2000)
While most available health impact studies use short-term functions, it should be worth
noticing that air pollution exposure can take effect after days. A following-up cohort
study suggests the association between chronic exposure and mortality rates for six
cities over a 35 year range.(Lepeule et. al., 2012) Chronic health impact is not
researched enough in previous studies compared with acute health impact. However,
chronic health impact has been associated with decreasing lung function in young
adults. (Tager et al., 2005) So it would be important to assess chronic health impact as
well to add to the existing references.

1.5 GLOBAL BURDEN OF DISEASE STUDIES
Global burden of disease (GBD) was first launched by World Bank and World Health
Organization in 1991 to close the gap between global challenges and lack of source
information. The GBD study provides a systemic approach to appraise information for
each condition in a critical way. (Murray et. al., 2013) Projection of future GBD is
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projected from 1990 to 2020 in Murray’s study as to help with decision making. (Murray
et. al., 1997) GBD provides the information of the morbidity or mortality over a global
range derived from air pollution so as to assess the impact over a global range. GBD
results can also provide insight into specific regional problems by providing the spatial
distribution of risk or mortality. Population distribution is considered as well as air
pollution concentration in GBD assessment of outdoor premature mortality.(Brauer et
al., 2012) In conclusion, GDB studies can be helpful in decision making and there is still
a lack of comprehensive air pollution derived premature mortality over a long time
range.
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CHAPTER TWO
LITERATURE REVIEW
Ambient fine particles (PM2.5), defined as particles less than 2.5 microns in aerodynamic
diameter, is found to be associated with daily mortality and cardiovascular mortality from
a study conducted in Shanghai. The compositions of PM2.5 include sulfate, nitrate,
organic carbon, elemental carbon, dust and biological materials while PM10 is mainly
composed of crustal material and primary organic materials. Although PM10 is also listed
as a critical pollutant, the results of this study actually indicate that there is no significant
association between PM10-2.5 and mortality. So it is logical and plausible to establish
PM2.5 as an indicator of particle health impact. (Kan et al., 2007) The starting
𝜇𝑔

concentration for the all six cities were less than 18 𝑚3 and each increase of 10 in PM2.5
is found to be associate with an increase of 14% in all-cause mortality, 26% in
cardiovascular mortality and 37% in lung-cancer mortality. As concentration vary from 8
to 15, the relation between chronic exposure to PM2.5 and all-cause, cardiovascular or
lung-cancer mortality is found to be linear. (Lepeule et. al., 2012) From the metaanalysis results from short-term exposure to fine particulate matter, SO42-, NO3-, EC and
OC are found to be positively associated with the increase in all cause, cardiovascular
and respiratory mortality with carbon being most strongly associated. (1.3% per 𝜇g/m3)
(Atkinson et. al., 2014)
Anthological activities have influenced air pollution and related health impact since
preindustrial times. This paper intends to look into the air pollution changes in the field
of fine particulate matter, or more specifically PM2.5, since preindustrial times that can
be attributed to anthological activities. Multiple models from the ACCMIP datasets are
used for the results comparison. Silvia’s paper looks into the global mortality changes
due to ozone and fine particulate matter concentration changes attributed from both
emission variation and climate change since preindustrial times. Concentration is
modeled by an ensemble of chemistry-climate models and Concentration response
functions(CRFs) are selected from American Chemical Society(ACS) studies to
calculate the global burden of disease distribution of air pollution related premature
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death. The results indicate that there are 470,000 premature respiratory resulted from
ozone and 2.1 million PM2.5 related cardiorespiratory disease (93%) and lung cancer
(7%) mortality. It indicates that climate change might have little influence on global
mortality. Silvia’s study estimated the mortality at a higher accuracy using 1,850 air
pollution modelling results instead of counterfactual low concentrations. But the CRFs
might cause additional deviation or uncertainty compared with integrated risk functions
when it comes to GBD calculation as the CRFs were originally used for America terrain.
There is large variation among different models. PM2.5 related mortality is widespread in
heavily populated regions including East Asia, India, Southeast Asia, Europe and
Former Soviet Union. One model (HadGEM2) estimates -283,000 deaths from PM2.5
decreases from climate change while the whole 5 models estimate 2,200 climate
change related mortality. The multi-model median mortality is 61,000 annual deaths
and would rise to 74,000 if HadGEM2 is excluded from the calculation. (Silva et al.,
2013)
In Cohen’s study (Cohen et al., 2006), mortality from PM exposure was studied for all
fourteen WHO regions with economic, meteorological and demographic data from 304
cities in the year of 2000. Years lost is utilized to calculate the burden of disease from
mortality from cardiopulmonary diseases and lung cancer in adults, together with acute
respiratory infection of school children as the estimation is made based upon US cohort
study derived risk coefficients. It is assumed in the study that there is a linear
association between death risk and PM2.5 mass concentration ranging from 7.5 to
50𝜇g/m3. Uncertainty might come from such assumption regarding both the response
curve shape and counterfactual level. For COPD, LC and ARI there are 3%, 5%, 1%
mortality contribution over a global horizon and those three diseases contribute up to
0.8 million premature death and 6.4 million years lost overall. The developing Asia takes
up two thirds of the global burden of outdoor air pollution. Cohen’s study includes only
urban area and excludes ozone impacts, thus might underestimating the PM2.5 health
effect.
In Anenberg’s paper (Anenberg et. al., 2010), long-term relative risk functions for ozone
and PM2.5 from epidemiology literature are utilized to simulate concentration instead of
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using measurement data. Measurement data may not include rural areas and
assumptions may be required for background air pollution. The results indicate that
3.5±0.9 million cardiopulmonary and 220,000±80,000 lung cancer mortalities (30 ± 7.6
million years of life lost) might be attributed to anthropogenic PM2.5 annually. Difference
in methodology lead to 50% difference in PM2.5 mortality estimation compared with
previous measurement derived results and that might be another reason why we should
expand the simulation studies. Observations show that there is an increase of
background concentration in remote regions since preindustrial times. A global
atmospheric chemical transport model is used to estimate mortality even for regions
with sparse air quality measurements. Anthropogenic air pollution is defined as the
changes in pollution concentration between preindustrial and present levels. The health
impact functions assume that there is a log-linear relationship between relative risk (RR)
and concentration. The RR function for PM2.5 is from Krewski’s study(Krewski et al.,
2009) with reanalysis of ACS studies. MOZART-2 is used to simulate pollutant
concentration with a resolution of 2.8° × 2.8°. PM2.5 is defined as SO4+NO3+BC+1.4*OC
with the assumption of unchanged concentration of dust, sea salt and secondary
organic aerosols.
According to Pope’s study (Pope et al., 2011), for lung-cancer mortality there is a nearly
linear association reaching RRs>40. When PM2.5 concentration is low, cardiovascular
disease accounts for higher proportion of mortality while lung cancer is more important
when concentration is high. In Apte’s study (Apte et. al., 2015), 10 km global data is
used for pollutant concentration and IER functions developed for global burden of
disease 2010 is utilized to estimate the attributable mortality effect from regional and
global air quality improvement. In relatively clean regions, modest improvement would
have large effect. While being in more polluted areas, major improvements would be
required to substantially reduce PM2.5 derived mortality. Five diseases including IHD,
stroke, COPD, LC, ALRI account for 20.1 million deaths in 2010.
In Wu’s paper (Wu et al., 2016), GISS-E2-R model was utilized for the relative change
in PM2.5 concentration from preindustrial time to future era. The results indicate that for
Jing-Jin-Ji area, which is located in China, will experience PM2.5 peak in 2020-2040. J.
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Lelieveld’s study (Lelieveld et. al., 2015) illustrates that the premature deaths derived
from PM2.5 pollution is predominant in Asia, especially India and China. There is also an
increasing trend of mortality as it would double by 2050 based on a business-as-usual
emission scenario. In Lelieveld’s paper, a secondary analysis is conducted under the
assumption that carbonaceous species are five times more toxic than crustal species,
nitrate and sulfate. For the reliability of SSP datasets, the analysis from Jiang’s
research (Jiang, 2014) actually indicates that the interactions implied by the
demographic assumptions in the SSPs fit the description from the literature results.
Some inconsistency issues might come from inconsistent definitions of regions and
limitations in the understanding of future interaction pattern changes through various
socioeconomic development stages.
IER model assumed that the toxicity of PM2.5 is only related to the mass exposure rather
than composition. Such assumption might be a little bit too general as the composition
of fine particle may vary greatly depending on different emission sources. In the IER
model, it is assumed that RRs are functions of PM2.5 mass concentration and are
independent of component distribution. (Burnett et al., 2014a) PM toxicity might vary on
account of composition. For example, carbonaceous specie has been shown to be more
toxic and is assumed to be five times more toxic than inorganic components in
Lelieveld’s paper. (Lelieveld et. al., 2015)
In Janssen’s paper (Janssen et al., 2011) that was based on the meta-analysis of 34
papers on time-series studies, the toxicity of black carbon particle was compared with
PM2.5. The adverse mortality effect of black carbon particle is larger than PM2.5 alone.
1𝜇g/m3 increase in PM2.5 is associated with 0.19% increase in all-cause mortality and
0.29% increase in cardiovascular mortality. For EC, there is 1.45% increase in all-cause
mortality and 1.77% increase in cardiovascular mortality. From long-term exposure
cohort studies, RR for EC is 7-16 times higher than that of PM2.5. There is 40%-70% EC
in PM2.5 of roadside source.
COPD is among the leading cause for global YLDs whether in 1990 and 2013. There is
an increase of 96.4% of heart failure from 1990 to 2013 and one third of that is caused
by ischaemic heart disease. (Bill et. al., 2015) It is estimated that 89% of the worldwide
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population has been exposed to PM2.5 contamination level that exceeds WHO air quality
guidelines with annual average level 10 𝜇𝑔/𝑚3 while 32% of the global population are
exposed to concentration exceeding 35 𝜇𝑔/𝑚3. It is estimated that 800,000 deaths and
6.4 million lost years are attributed to fine particulate matter exposure in 2000. In
Brauer’s study (Brauer et al., 2012), TM5 and satellite remote sensing data were
averaged to indicate the concentration level over a global range. SAT approach, which
measures the concentration level according to satellite observation of AOD, provides
data even for regions without proper ground-level measurement data.
One long-term Cohort study (Cao et al., 2011) in China indicate that there is significant
association between air pollution and mortality from cardiopulmonary disease and lung
cancer through proportional hazards regression model. 14 WHO regions in 2000 were
investigated for economic, meteorological, demographic and PM data to estimate the
burden of disease. PM2.5 concentration was achieved by PM10 concentration and
available spatial distribution of PM2.5/PM10 ratio. It is assumed that there is linear
correlation between PM2.5 concentration and risk within 7.5 and 50 𝜇𝑔/𝑚3 . PM2.5
pollution is estimated to be responsible for 3% of adult cardiopulmonary mortality, 5% of
trachea, bronchus, lung cancer mortality and 1% of acute respiratory disease derived
mortality among children in the GBD analysis. Developing countries contribute majorly
to the global burden of disease while Asia specifically contributes two-thirds of the GBD.
(Cohen et al., 2006)
Asides from the probability of health impact from persistent exposure to high
concentration of PM, it is also found that low concentration of PM may still pose as
health risk regarding non-accidental and cardiovascular mortality. From the cohort study
of Canadians, mortality is found to be associated with long-term PM2.5 exposure even at
mean concentration of 8.7 𝜇𝑔/𝑚3 from the output of standard Cox models.(Crouse et
al., 2012) SeaWiFS and MIRS are combined with GEOS-Chem to derive the first global
𝜇𝑔

satellite PM2.5 estimate at a grid size of 10km*10km. There has been 0.55 𝑚3 /𝑦𝑒𝑎𝑟
(2.1%/year) increase from 1998 to 2012 regarding global population weighted PM 2.5
concentration. (Donkelaar et. al., 2014)
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CHAPTER THREE
METHODOLOGY
3.1 PARTICULATE CONCENTRATION
The Atmospheric Chemistry and Climate Model Intercomparison Project (ACCMIP)
includes a series of time slice experiments that are conducted to reveal the long-term
changes in atmospheric composition and radiative forcing from preindustrial times to
recent years and predict the effects further into the future. The time scale ranges from
1850 to 2100. Among all the four RCP scenarios, RCP 6.0 includes short lived
precursor emissions that are different from the others while RCP 2.6 and RCP 8.5
provide the extremes in 2100 climate change or methane levels. The PM2.5 data are
included in the following models: GISS-E2-R, GFDL-AM3, CICERO-OsloCTM2, NCARCAM3.5, NCAR-CAM5.1, MIROC-CHEM, HadGEM2.(Lamarque et al., 2013)
PM2.5 mass calculation for models without direct PM2.5 output is calculated using:
PM2.5=BC + OA + SO4 + SOA + NO3 + NH4 + 0.25*SS + 0.1*Dust
Gridded PM2.5 or components data are collected from different models and various
sceneries as input. To facilitate the usage of population data and make different model
comparable, model regrid was applied to original data converting the different gridded
concentration data to the same grid (0.5°*0.5°).

3.2 POPULATION DATASETS
Population data for 1980-2100 was collected from the Center for global environmental
research to calculate mortality.

3.2.1 SSPs scenarios
In the SSP1 scenario, the future is in a sustainable pathway with education and health
investment. The population would be low and the human well-being is being heavily
emphasized. SSP2 scenario assumes medium fertility with medium mortality, medium
migration and medium education level while SSP3 refers to a world that population
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growth is mainly in developing countries. SSP4 considers the future world of high
inequalities. SSP5 indicates a world that emphasizes technological progress and
economic growth. (KC et. al., 2014)

3.2.2 The advantage of SSPs
For climate change related research, the Shared Socio-economic Pathways (SSPs) has
also been used as demographic data input. For example, in Lutz’s research, the
variation in population size and structure were studied regarding the contribution
towards greenhouse gas emission and capacity of adapting to climate change. IPCCSRES (Intergovernmental Panel on Climate Change—Special Report on Emissions
Scenarios) scenarios only include trajectories for total population size, SSPs address
the predicted trajectories for all age, sex and education details for all countries. (Lutz et.
al., 2015) When measuring the total mortality from IHD, the mortality distribution is
closely associated with age. So more detailed prediction would be required to achieve
the results.

3.3 PM2.5 DERIVED RRS AND MORTALITY BASED UPON IER MODEL
3.3.1 RRs value
The IER functions developed by Burnett are used for assessing the global burden of
disease is as below.
For the calculation of relative risk value:
For z< zcf,
RRIER(z)=1
When exposure level is lower than the threshold, there would be no additional health
risk since RR=1 means the risk is exactly the baseline.
For z≥ zcf,
RRIER(z)=1+𝛼{1 − exp[−𝛾(𝑧 − zcf )𝛿 ]}
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For exposure larger than threshold value, relative risk is larger than 1 and the increase
is determined by the difference between exposure level and threshold level, disease
endpoint parameters (𝛼, 𝛾, 𝛿).
Z-exposure to PM2.5 (𝑢𝑛𝑖𝑡: 𝜇𝑔/𝑚3 )
𝑧𝑐𝑓 − 𝑐𝑜𝑢𝑛𝑡𝑒𝑟𝑓𝑎𝑐𝑡𝑢𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑏𝑒𝑙𝑜𝑤 𝑤ℎ𝑖𝑐ℎ 𝑡ℎ𝑒𝑟𝑒 𝑖𝑠 𝑛𝑜 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑟𝑖𝑠𝑘
The unknown parameter sets (𝛼, 𝛾, 𝛿) are estimated by nonlinear regression methods
and there are different parameter values for various locations or diseases. The
advantage of IER model compared with traditional concentration-response (CR)
functions is that this model can be applied to global range analysis without causing too
much uncertainty associated with the limitation of endpoints.(Burnett et al., 2014a) The
lookup table from Apte’s study (Apte et. al., 2015) was utilized to calculate the RRs for
this study. The three main chronic diseases related to PM2.5 concentration variation are
COPD (chronic obstructive pulmonary disease), LNC (lung cancer), LRI (lower
respiratory infection). It indicates that IER model is superior in predicting RR compared
with seven other forms of models in previous references. RR values were calculated
with the IER model data of 1000 endpoints from apte’s research to generate the relative
risk values for COPD, LRI, LNC, IHD that are associated with PM2.5 mass concentration
variation from a time range of 1850 to 2100.
3.3.2 Mortality value
The mortality rate in each grid is calculated as below:
𝑀𝑖,𝑗 = 𝑃𝑖 × 𝐼̂𝑗,𝑘 × (𝑅𝑅𝑗 (𝐶𝑖 ) − 1)
𝐼̂𝑗,𝑘 =

𝐼𝑗,𝑘
̅̅̅̅𝑗,𝑘
𝑅𝑅

𝑃𝑖 − 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑔𝑟𝑖𝑑 𝑐𝑒𝑙𝑙 i
𝐼𝑗,𝑘 − 𝑟𝑒𝑝𝑜𝑟𝑡𝑒𝑑 𝑟𝑒𝑔𝑖𝑜𝑛𝑎𝑙 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑎𝑛𝑛𝑢𝑎𝑙 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑐𝑒 𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 𝑟𝑎𝑡𝑒 𝑓𝑜𝑟
𝑒𝑛𝑑𝑝𝑜𝑖𝑛𝑡 𝑗 𝑖𝑛 𝑟𝑒𝑔𝑖𝑜𝑛 𝑘
𝐶𝑖 − 𝑎𝑛𝑛𝑢𝑎𝑙𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑃𝑀2.5 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑖𝑛 𝑐𝑒𝑙𝑙 𝑖
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𝑅𝑅𝑗 (𝐶𝑖 ) − 𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑟𝑖𝑠𝑘 𝑓𝑜𝑟 𝑒𝑛𝑑𝑝𝑜𝑖𝑛𝑡 𝑗 𝑎𝑡 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝐶𝑖

Population normalized RR value:
̅̅̅̅𝑗,𝑘 =
𝑅𝑅

∑𝑁
𝑖=1 𝑃𝑖 × 𝑅𝑅𝑗 (𝐶𝑖 )
∑𝑁
𝑖=1 𝑃𝑖

Population normalization is useful in adjusting exposure level. For example, there is grid
A and grid B with the same risk value derived from concentration and the population is
100 in grid A while the population is 0 in grid B. The exposure in grid B would not add to
the normalized value since no population means no exposure while grid A would add to
the normalized value by the extent limited by population in grid A. This example
illustrates that normalization is an effective way to measure human related exposure.
Spatial distribution of PM2.5 concentration would be only relevant to the measurement
when the population is not blank. Non-populated areas including oceans can be
excluded from contributing to the exposure calculation while highly-populated areas
would further add to calculation.
The change in mortality: ∆𝑀𝑖,𝑗 =𝑃𝑖 × 𝐼̂𝑗,𝑘 × (𝑅𝑅𝑗 (𝐶𝑖∗ ) − 𝑅𝑅𝑗 (𝐶𝑖 ))
Since there might be multiple risk factors for point estimates, it is not accurate to
describe the reduction in attributable mortality as “lives saved”. It can be regarded as
the reduction of mortality statistically under certain scenario with given data and
parameters. The result is statistically significant but may not be associated with one or
two human being as speaking. The change in mortality between baseline situation and
hypothetical situation would be an insight into policy making.
The simplified mortality change function from Lelieveld’s paper (Lelieveld et al.,
2015)( ∆𝑀𝑜𝑟𝑡 = 𝑦0 [(RR-1)/RR]Pop ) is applied to the calculation.
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3.4 INTEGRATION AND COMPARISON
3.4.1 The world regions and related integrated data
UN divides the world into 10 regions in the UN Millenium Development Goals (MDG)
regions according to development extent. The MDG regions include developed
countries (DC), caucasus and central Asia (CIS), Northern Africa (NA), Latin America
and the Carribbean (LAC), Eastern Asia (EA), Southern Asia (SA), South-eastern Asia
(SEA), Western Asia (WA) and Oceania (O).1 The development extent of regions would
be an important consideration since both population and anthological emission could be
related to the development extent. Figure 1 is the UN division map.
3.4.2 The reason for using three year average data
For long-term climate change and pollution changes, one year data would be not
sufficient enough to represent a decade. So for common long-term climate change or
pollution variation studies, the way to represent decade data is to use multi-year
average.
3.4.3 Time series
1850 is used to describe the air pollution related health impact in the past at the end of
industrial evolution. 2000 is used to represent the current years. 2030 would be a good
indicator for the sustainability achievements for the future. It is predicted by UN that at
the time of 2050, 70% of world population to be crammed into poor, overcrowded,
polluted urban areas so the mortality variation based upon air pollution and population
would be a major problem in the future.2 The year around 2050 should a good indicator
of future scenarios.
3.4.4 Comparison
The output RRs and mortality are compared within different sceneries and models.
Comparisons are also made between our study and other studies found in the literature.

1

http://mdgs.un.org/unsd/mdg/Host.aspx?Content=Data/RegionalGroupings.htm
https://aftermathnews.wordpress.com/2010/03/24/un-by-2050-70-of-world-population-to-be-crammed-into-poor-overcrowdedpolluted-urban-corridors-comprising-a-tiny-fraction-of-habitable-land/
2
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Figure 1 UN regions3

3

http://nuclearsuntan.blogspot.com/2011/11/un-divides-world-into-10-regional.html
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3.5 UNCERTAINTY MEASUREMENT
3.5.1 Uncertainty in concentration data
The variation in RRs and ∆𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 between various climate models and different
sceneries are calculated for each spatial grid and each MDG region. For various
radiative forcing scenarios, best scenario (RCP 2.6) with +2.6W/m2 increased forcing is
theoretical quite different from the worst scenario (RCP 8.5) with +8.5W/m2. What effect
would various scenarios cast upon the projection, the association between radiation
forcing and near surface fine particle concentration and the possible future coming from
worst scenario are taken into consideration when analyzing the problem. RCP 2.6 and
RCP 8.5 provide extremes in 2100 climate change and methane levels. RCP 6.0 is
significantly different than the others since it contains very different short-lived precursor
emissions. (Lamarque et al., 2013)
Furthermore, various models depict the distribution differently due to the mechanism.
Natural emission alone can cause the significant variation among models. NCARCAM5.1 and GISS-E2-R describe aerosols in an extensive way. Representation of nonmethane hydrocarbon chemistry varies among different models, which is responsible for
different model performance. Aerosol in NCAR-CAM5.1 is represented by three
internally-mixed log- normal modes (Aitken, accumulation, and coarse) while aerosol in
GISS-E2-R is represented by 108 size-resolved aerosol tracers plus three bulk aerosolphase tracers. LMDzORINCA model uses a modal approach to simulate the distribution
of aerosols. All other models use the bulk approach. Models except GISS-E2-R
includes limited heterogeneous reactions. Half of all ACCMIP models include the
indirect effect of aerosols. Since different models work differently, there is no way of
assuming any model has the best prediction results. Some models do predict with
higher sensitivity for certain regions. In atmospheric or climate change related modelling
studies, multi-ensemble is used to increase projection accuracy.
In Fowler’s study (Toggweiler et.al., 2001), multi-model ensemble is used to assess the
precipitation extremes in UK. Ensemble generally increase the skill, reliability and
consistency of predictions compared with single model so that it would be useful in
lowering projection errors. In climate models, the equally weighted average of several
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models is usually found to agree better than any single models. In IPCC reports,
unweighted multi-model means is usually used to present best guess projection instead
of one model. (Tebaldi et. al., 2007) Since it is complicated to determine the weight for
each model, unweighted mean would be used in this study to output the ensemble
results.
3.5.2 Uncertainty in population data
The variation of mortality caused by various sceneries of population (SSP1, SSP2,
SSP3) is calculated for each grid and UN region. Since SSP1 represents the
sustainable population pathway, SSP2 indicates intermediate challenges while SSP3 is
the scenario of fragmentation, the projection of mortality and population normalized
relative risk or PM2.5 concentration exposure can be varied due to the various
assumptions of future population distribution and total number.
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CHAPTER FOUR
RESULTS
4.1 SEASONAL DISTRIBUTION OF RRS FROM GISS-E2-R MODEL
OUTPUT
For relative risk values, the value 1 is regarded as baseline which means there is no
additional health risk and the larger risk value indicates elevated risk. For example, in
regions with risk of 2, the exposure health impact is twice of that of baseline or
background. So, if the population distribution does not change, the premature mortality
caused by certain disease from time A should be twice of the mortality value from time
B for the same region. Risk is an extent to which exposure might influence the
population living in certain region, so population is a major factor in determining how
influential it is of health relative risk. Population normalization and mortality is calculated
to make such linkage.
In some cases, a value slightly less than 1 was calculated due to the data processing. In
these cases, it does not mean the risk is actually reduced since there is no way of
having a risk value less than the background. Risk values less than 1 should be treated
as 1 but such values does mean than the near surface concentration is so low
compared with health impact function that no additional risk should be considered.
Figure 2-3, 50-51, 52-53 depict the monthly relative risk for COPD, LNC, LRI
respectively in 1850s from the data collected and averaged from GISS-E2-R model
outputted PM2.5 concentration.
Figures 54 - 59 depict the monthly relative risk for COPD, LNC, LRI respectively in
1860s from the data collected and averaged from GISS-E2-R model outputted PM2.5
concentration.
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Figure 2 Global relative risk for cardiopulmonary disease from January to June of the three year average data from
1850 to 1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.
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Figure 3 Global relative risk for cardiopulmonary disease from July to December of the three year average data from
1850 to 1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.
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From the spatial distribution of relative risk for cardiopulmonary disease (RRCOPD)
over the global terrain in pre-industrial times, it is observed that there is a widely
distributed elevated RR value in September compared with previous month. The peak
value start to spread from northern Africa to Western Asia and southern Asia since May.
The risk peak in Western and Southern Asia start to decrease since October. Overall
there is only a slight elevation of relative risk of COPD disease due to PM2.5 surface
concentration while the highest peak exist in Africa regions. The RR value for the whole
globe ranges from 1.02 to 1.7, which indicates that health risk is not elevated for the
preindustrial times. The relative risk of LNC ranges from to 2.05 with relatively lower
concentration levels in February and July. LRI disease risk is more varied compared
with COPD and LNC. There is a slight elevation in RR value for COPD in 1860s
compared with 1850s with an increase from 1.7 to 2.24.
LNC risk value is majorly elevated as the peak value has increased from 2.05 in 1850 to
3.05 in 1860. The elevation indicates a major increase in fine particulate induced lower
respiratory infection health risk in the pre-industrial times. The relative risk is overall low
in August. Such output means that for maximum exposure regions the risk for lung
cancer due to air pollution has increased from twice the baseline to three times the
baseline.
Figure 60-61, 62-63, 64-65 describe the disease risk for COPD, LNC, LRI respectively
in 2000s. Figure 66-67, 68-69, 70-71 depict the relative risk for COPD, LNC, LRI
respectively in 2030s. Figure 4-5, 72-73, 74-75 depict the relative risk for COPD, LNC,
LRI respectively in 2050s.
The risk value is much elevated in eastern Asia in April and May, then it start to
decrease in June and increase to a higher level again in August, September and
October. The reason for such seasonal variation might be partially due to seasonal
change in Asia dust storm.
The RCP2.6 scenario actually assumes the best emission situation as the emission of
all three major greenhouse gas species (CO2, CH4, N2O) are projected to keep
decreasing since 2000s. The comparison between 1850s and 2050s (under RCP2.6
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scenario) shows that there is not much difference between the seasonal distribution and
overall risk elevation levels of preindustrial times and future era.
It shows a widespread elevation in RR values all over the globe in April since 1900s.
There is a lower level of RR distribution in May, Jun, July for future times compared with
current years from the comparison of 1900s-2000s and 2030s-2050s.

4.2 ANNUAL PLOT OF GISS-E2-R MODEL OUTPUT
Figure 6-9 describe the annual relative risk of COPD endpoint plot from 1850s to 2090s
from GISS-E2-R with RCP2.6 as the future emission scenario.
The annual plot of COPD relative risk distribution from 1850 to 2090 shows that there
are lower levels of COPD relative risk for the time of 1860s, 1910s, 1970s while there is
a relatively high level in 1850s. COPD relative risk value varies from 1.02 to 1.58. The
elevated value starts emerge in southern Asia since 1980s and emerge in south-eastern
Asia since 2000s. The elevated level is projected to disappear since 2050s.
The spatial distribution of LRI (figure 5) is very consistent all through the time period.
There starts to be an elevated risk value in southern Asia since 1980s and it is projected
to last till 2060s. Aerosol loading has increased substantially in South and East Asia
since 1979 with high level of PM2.5 distributed in eastern, southeastern, northern and
northwestern China, northern India and part of Southeast Asia. Aerosol optical depth
satellite results indicate the general positive trend in PM2.5 concentration projection over
China for the past few decades. The emission in eastern Asia, especially China, can
vary hugely according to the government policy. Dust storm also has an impact upon
the PM2.5 variation. (EANET, 2015)
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Figure 4 Global relative risk for cardiopulmonary disease from January to June of the three year average data from
2050 to 2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.
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Figure 5 Global relative risk for cardiopulmonary disease from July to December of the three year average data from
2050 to 2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.
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Figure 6 Global relative risk for cardiopulmonary disease for 6 time periods from 1850s to 1900s with the ambient
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for
COPD disease endpoint. Note that the Saharan dust regions might present an elevated relative risk all through 6
decades and there is no other obvious increase of risk in other regions.
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Figure 7 Global relative risk for cardiopulmonary disease for 6 time periods from 1910s to 1960s with the ambient
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for
COPD disease endpoint. Note that the peak value might be higher than previous decades.
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Figure 8 Global relative risk for cardiopulmonary disease for 6 time periods from 1970s to 2020s with the ambient
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for
COPD disease endpoint. Note that eastern Asia and other parts of Asia are associated with risk elevation since
2000s.
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Figure 9 Global relative risk for cardiopulmonary disease for 7 time periods from 2030s to 2090s with the ambient
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for
COPD disease endpoint. Note that the elevation in Asia start to decrease since 2040s with peak value in Saharan
and Australia consistent all through the time period.
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Figure 10 Global relative risk for lung cancer for 6 time periods from 1850s to 1900s with the ambient PM2.5
concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett et al.,
2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot indicate the
level of relative risk over a global terrain by applying the concentration-risk function from IER model for LNC disease
endpoint.
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Figure 11 Global relative risk for lung cancer for 6 time periods from 1910s to 1960s with the ambient PM2.5
concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett et al.,
2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot indicate the
level of relative risk over a global terrain by applying the concentration-risk function from IER model for LNC disease
endpoint.
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Figure 12 Global relative risk for lung cancer for 6 time periods from 1970s to 2020s with the ambient PM2.5
concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett et al.,
2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot indicate the
level of relative risk over a global terrain by applying the concentration-risk function from IER model for LNC disease
endpoint.
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Figure 13 Global relative risk for lung cancer for 7 time periods from 2030s to 2090s with the ambient PM2.5
concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett et al.,
2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot indicate the
level of relative risk over a global terrain by applying the concentration-risk function from IER model for LNC disease
endpoint.
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Figure 14 Global relative risk for lower respiratory infection for 6 time periods from 1850s to 1900s with the ambient
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for
LRI disease endpoint.

34

Figure 15 Global relative risk for lower respiratory infection for 6 time periods from 1910s to 1960s with the ambient
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for
LRI disease endpoint.
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Figure 16 Global relative risk for lower respiratory infection for 6 time periods from 1970s to 2020s with the ambient
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for
LRI disease endpoint.
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Figure 17 Global relative risk for lower respiratory infection for 7 time periods from 2030s to 2090s with the ambient
PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed for GBD(Burnett
et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude. The map plot
indicate the level of relative risk over a global terrain by applying the concentration-risk function from IER model for
LRI disease endpoint.

37

The annual spatial distribution of LNC risk shows the relatively low level all through the
time periods with a relatively high risk level in 1850s. The risk peak in northern Africa
regions is persistent all through all seasons and years due to the possible impact from
massive Saharan dust storms. With the transport of Saharan dust, some regions of
Europe might display positive effect of dust storm fine particle related health impact of
cardiac, respiratory mortality but the effect might still be not statistically significant.
(Karanasiou et al., 2012) It is found that Saharan dust can transport to regions
including United States, the Caribbean and South America, western Mediterranean,
Europe, eastern Mediterranean and the Middle East. The elevation of risk in those
regions is partially attributed from the Saharan dust storm.
The Saharan region and its surroundings are responsible for 600 to 900Tg of
atmospheric dust annually, accounting for half of the global total dust emission. The
impact from Saharan dust would increase the relative risk due to its large amount of
presence. The health risk from PM10 in Saharan dust is widely documented since daily
PM10 concentration might rise to a level as high as a daily value of 4024𝜇𝑔/𝑚3 in
extreme situation. (de Longueville et al., 2013) The elevated risk in the Saharan
regions and surroundings in this study might be an indication of such problem. The dust
loadings might change substantially due to climate change so it would be interesting to
look into the long-term change in the dust storm particulates emission. (Goudie et. al.,
2001)

4.3 MIROC-CHEM MODEL OUTPUT
Figure 18 depicts the relative risk output from MIROC-CHEM model under RCP2.6
scenario with a time range from 1850s to 2050s.
Compared with GISS-E2-R model, MIROC-CHEM predicts an elevated relative risk in
the region of Chile. The risk level in northern and Sub-Saharan Africa remains high all
through the time periods. The risk level in eastern Asia is elevated since 1980s and the
level start decreasing from 2030s. There is also an obvious elevation in Europe in
1980s, which is consistent with the output from the GISS-E2-R model.

38

Lower respiratory infection (Figure 19) relative risk values are generally higher than
other two diseases. Lower respiratory infection is more sensitive to exposure of surface
PM2.5 concentration than cardiopulmonary disease or lung cancer. The reason for that is
the reatlive risk value for LRI is higher than COPD and LNC when PM2.5 concentration
exceeds 20.2 𝜇𝑔/𝑚3 from IER RR value table.(Apte et al., 2015)
There is a widespread elevated risk level in the 1930s for lung cancer disease. The
elevated values in central Asia in the 1850s are no longer perceived in other eras. The
difference between 1850s and 1930s might be attributed to the Gobi desert dust storm.
(Figure 20)

4.4 RCP SCENARIO COMPARISON
RCP scenarios describe the trend of greenhouse gas emission in the future with RCP
2.6 being the best scenario with the radiation forcing increase of +2.6W/m2 by 2100 and
the emission is cut by 40% in 100 years with RCP8.5 being the worst scenario with the
radiative forcing increase of +8.5W/m2 as the prediction of GtC increase in an order of
15 to 20 by 2100.
Figure 21 depicts the trend of emission of main greenhouse gases across all RCPs.
Emission trends of air pollutants are determined by the change in driving force, the
assumed air pollution control policy and the assumed climate policy. All the RCP
scenarios assume that air pollution emissions would decrease in the future as a general
trend. But generally the best greenhouse gas emission scenario RCP 2.6 is associated
with the best scenario in air pollution emission while the worst greenhouse gas emission
scenario RCP 8.5 is associated with the worst. Only the general trend is as described
as above, but the trend in specific regions or at specific time is still undetermined.
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Figure 18 Global relative risk annual plot for cardiopulmonary disease from 1850s to 2050s of the three year average
data from the ambient PM2.5 concentration output from MIROC-CEHM model based on the integrated risk function
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentrationrisk function from IER model for COPD disease endpoint.
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Figure 19 Global relative risk annual plot for lower respiratory infection disease from 1850s to 2050s of the three year
average data from the ambient PM2.5 concentration output from MIROC-CEHM model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.

41

Figure 20 Global relative risk annual plot for lung cancer disease from 1850s to 2050s of the three year average data
from the ambient PM2.5 concentration output from MIROC-CEHM model based on the integrated risk function
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentrationrisk function from IER model for LNC disease endpoint.
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Figure 21 Emissions of main greenhouse gases CO2, CH4, N2O from 2000 to 2100 across all RCPs4. The four RCPs,
RCP2.6, RCP4.5, RCP6.0, and RCP8.5, refer to a possible range of radiative forcing values in the year 2100
compared with pre-industrial values (+2.6, +4.5, +6.0, and +8.5 W/m2, respectively) For CO2 and N2O, the emission
amount increase from 2000 to 2100 from highest to lowest is RCP8.5, RCP6.0, RCP4.5, RCP2.6. For methane
emissions, RCP4.5 and RCP 6 share similar trajectory all through the time.

4 https://www.skepticalscience.com/RCP.php?t=3#trajectories
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Figure 22 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for PM2.5 surface concentration from MIROCCHEM model output in 2030s. The ambient PM2.5 concentration is the three year average of 2030, 2031, 2032 with
unit of µg/m3. RCP8.5 depicts the worst scenario, especially in Asia.
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Figure 22 describes the PM2.5 concentration comparison between RCP2.6, RCP6.0.0
and RCP8.5 scenarios for 2030 projection from MIRCO-CHEM output.
The surface fine particle level is high in RCP8.5 scenario and low in RCP2.6
scenario, especially for the Asian region. The highest radiative forcing (RCP8.5)
scenario is associated with the heaviest pollution level in Asia and the Saharan
regions. The reason is that dust in dry regions, especially smaller particles, tends to
be lofted into the air by wind erosion. So it is possible that dryer and hotter weather
patterns in certain regions caused by climate change would increase the intensity or
frequency of dust storm activities.
However, the effect of climate change upon dust activities might be complicated and not
just limited to air lofting. For example, dust particles both reflect and absorb sunlight and
thus reducing the surface temperature. At the same time, the radiative forcing variation
would alter the sea-land circulation and affect wind activities. Climate change would
also alter monsoon and thus influencing dust storm activities since dust particles cannot
travel long distances under very wet conditions and rainfall would cause precipitation of
particles. (Miller et. al., 1998)
Overall, all those interactions would contribute to the alteration in dust activities.
The output shows the generally increased severity of dust storm effect in the Saharan
regions, which indicates that larger wind erosion might occur with higher radiative
forcing.
Figure 23 depicts relative risk of cardiopulmonary disease from MIROC-CHEM model at
2030 from RCP2.6, RCP6.0.0, RCP8.5 scenarios. Figure 24 depicts lower respiratory
infection risk while figure 25 depicts lung cancer risk from MIROC-CHEM model at 2030
from RCP2.6, RCP6.0.0, RCP8.5 scenarios respectively.
RCP8.5 has the highest projected level of COPD relative risk in the 2030s. Radiative
forcing is the factor influencing the variation.
LRI has very varied relative risk value distribution from various scenarios. RCP6.0.0
has a relatively higher level in Europe region and eastern Asia than other scenarios.
(Figure 24)
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RCP6.0 has the highest prediction for elevated surface PM2.5 concentration level in
eastern Asia and Australia.
RCP 6.0 predicts a higher level of RR in eastern Asia, south-eastern Asia as well as
western Asia compared with other scenarios in 2030s.
GISS-E2-R has a higher prediction of LRI risk in 2030s than MIROC-CHEM model.
Figure 26 describes the PM2.5 concentration comparison between RCP2.6, 6.0 and 8.5
for 2050 projection from MIRCO-CHEM output. RCP6.0 pictures 2050s as more
elevated in East Asia while RCP8.5 depicts the high concentration in Saharan regions.
Figure 27, 28, 29 depict the relative risk value comparison between RCP2.6, 6.0 and
8.5 for COPD,LNC,LRI respectively for 2050 projection from MIRCO-CHEM.
The highest risk elevation in Asia is for RCP6.0.0 scenario while the highest risk
elevation in northern Africa is for RCP8.5 scenario in 2050s.
For the MIROC-CHEM model output in 2050s, RCP6.0.0 predicts an elevated level in
eastern Asia while RCP8.5 predicts a higher level in southern Africa.
So the relative risk for LNC is elevated in eastern and south-eastern Asia for RCP6.0.0
while it is elevated in western and southern Asia for RCP8.5. RCP8.5 also predicts an
elevated level in southern Africa.
Figure 30 describes the PM2.5 concentration comparison between RCP2.6,4.5, 6.0 and
8.5 for 2050 projection from GISS-E2-R output.
RCP 6.0 is the only scenario that predicts elevated PM2.5 in eastern Asia for 2050s.
Figure 31 describes the COPD relative risk comparison between RCP2.6,4.5, 6.0 and
8.5 for 2050 projection from GISS-E2-R output.
RCP 6.0 predicted an elevated risk level in eastern Asia in 2050s.
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Figure 23 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for cardiopulmonary disease relative risk from
MIROC-CHEM model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032. RCP8.5
depicts the worst scenario, especially with a widespread elevation in relative risk over Asia.
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Figure 24 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for lower respiratory infection disease relative risk
from MIROC-CHEM model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032.
RCP8.5 depicts the worst scenario, especially with a widespread elevation in relative risk over Asia.
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Figure 25 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for lung cancer relative risk from MIROC-CHEM
model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032. RCP8.5 depicts the
worst scenario, especially with a widespread elevation in relative risk over Asia.
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Figure 26 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for PM2.5 surface concentration from MIROCCHEM model output in 2050s. The ambient PM2.5 concentration is the three year average of 2050, 2051, 2052 with
unit of µg/m3. RCP8.5 depicts the worst scenario, especially in Asia.
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Figure 27 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for cardiopulmonary disease relative risk from
MIROC-CHEM model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. RCP8.5
depicts the worst scenario, especially with a widespread elevation in relative risk over Asia.
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Figure 28 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for lung cancer relative risk from MIROC-CHEM
model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. RCP8.5 depicts the
worst scenario, especially with a widespread elevation in relative risk over Asia.

52

Figure 29 RCP scenarios (RCP2.6, RCP6.0, RCP8.5) comparison for lower respiratory infection relative risk from
MIROC-CHEM model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052. RCP8.5
depicts the worst scenario, especially with a widespread elevation in relative risk over Asia.

53

Figure 30 RCP scenarios (RCP2.6, RCP4.5, RCP6.0, RCP8.5) comparison for PM2.5 concentration (unit:µg/m3) from
GISS-E2-R model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032.
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Figure 31 RCP scenarios (RCP2.6, RCP4.5, RCP6.0, RCP8.5) comparison for cardiopulmonary disease relative risk
from GISS-E2-R model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032.
RCP6.0 scenario predicts the highest risk level in eastern Asia.
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Figure 32 RCP scenarios (RCP2.6, RCP4.5, RCP6.0, RCP8.5) comparison for lung cancer relative risk from GISSE2-R model output in 2030s. The relative risk output is the three year average of 2030, 2031, 2032. RCP6.0 scenario
predicts the highest risk level in eastern Asia.

56

Figure 33 RCP scenarios (RCP2.6, RCP4.5, RCP6.0, RCP8.5) comparison for lower respiratory infection disease
relative risk from GISS-E2-R model output in 2030s. The relative risk output is the three year average of 2030, 2031,
2032. RCP6.0 scenario predicts the highest risk level in eastern Asia.
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Figure 34 RCP scenarios (RCP2.6, RCP4.5, RCP6.0.0, RCP8.5) comparison for PM2.5 concentration (unit: µg/m3)
from GISS-E2-R model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052.
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Figure 35 RCP scenarios (RCP2.6, RCP4.5, RCP6.0.0, RCP8.5) comparison for cardiopulmonary disease relative
risk from GISS-E2-R model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052.
RCP6.0.0 scenario predicts the highest risk level in eastern Asia.
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Figure 36 RCP scenarios (RCP2.6, RCP4.5, RCP6.0.0, RCP8.5) comparison for lung cancer disease relative risk
from GISS-E2-R model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052.
RCP6.0.0 scenario predicts the highest risk level in eastern Asia.
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Figure 37 RCP scenarios (RCP2.6, RCP4.5, RCP6.0.0, RCP8.5) comparison for lower respiratory infection relative
risk from GISS-E2-R model output in 2050s. The relative risk output is the three year average of 2050, 2051, 2052.
RCP6.0.0 scenario predicts the highest risk level in eastern Asia.
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4.5 COMPARISON BETWEEN MODELS

Figure 38 The comparison of ambient PM2.5 concentration between various models (CICERO-OsloCTM2, MIROCCHEM, NCAR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R) in 1850s. CICERO-OsloCTM2 predicts surface
concentration in an obvious different way compared with other models while NCAR-CAM3.5 has a generally higher
prediction.
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Figure 39 multi-ensemble results for COPD relative risk for 1850s with the unweighted average of cardiopulmonary
relative risk from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R.

Figure 40 multi-ensemble results for LNC relative risk for 1850s with the unweighted average of lung cancer relative
risk from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R.
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Figure 41 Multi-ensemble results for lower respiratory infection relative risk for 1850s with the unweighted average of
lung cancer relative risk from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R.
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Figure 42 The comparison of ambient PM2.5 concentration between various models (CICERO-OsloCTM2, MIROCCHEM, NCAR-CAM3.5, NCAR-CAM5.1, GISS-E2-R, GFDL-AM3) in 2000s. CICERO-OsloCTM2 predicts surface
concentration in an obvious different way compared with other models while GFDL-AM3 has a generally higher
prediction.
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Figure 43 Multi-ensemble results for cardiopulmonary disease relative risk for 2000s with the unweighted average
from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1, GISS-E2-R and GFDL-AM3.
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Figure 44 Multi-ensemble results for lung cancer relative risk for 2000s with the unweighted average output from
models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1, GISS-E2-R and GFDL-AM3.

Figure 45 Multi-ensemble results for lower respiratory infection relative risk for 2000s with the unweighted average
output from models including MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1, GISS-E2-R and GFDL-AM3.
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Figure 46 Multi-ensemble results for dust concentration for 2000s with the unweighted average from models including
MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1, GISS-E2-R and GFDL-AM3.

Figure 38 describes the model comparison for pre-industrial projection of near surface
PM2.5 concentration from CICERO, MIROC-CHEM, NACR-CAM3.5, NCAR-CAM5.1 and
GISS-E2-R.
NCAR-CAM3.5 has a much higher level of PM2.5 output for 1850s. CICERO-OsloCTM2
has a very different output compared with other models which can be explained by the
lack of continuous data around 1850 and the cumulated deviation of adding up
composition components.
Model comparison shows the outliner value for CICERO, so this model would not be
used for multi-model ensemble. Models comparison for 1850s shows obvious elevation
of relative risk of LRI for NACR-CAM3.5.
Figure 39,40,41 show the ensemble results from MIROC-CHEM, NACR-CAM3.5,
NCAR-CAM5.1, GISS-E2-R for relative risk of COPD,LNC,LRI in 1850s. The ensemble
results provide the distribution of risk with lower uncertainty from model difference.
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Figure 42 describes the model comparison for current year (2000s) projection of near
surface PM2.5 concentration from GFDL-AM3, CICERO-OsloCTM2, MIROC-CHEM,
NACR-CAM3.5, NCAR-CAM5.1 and GISS-E2-R. Compared with 1850s, NCAR-CAM3.5
predicts an elevated level in southern America. GFDL-AM3 predicts a commonly
elevated value over the globe and it is shown that the Saharan dust pollution spread to
further range than other models. While GISS-E2-R predicts an elevation in central
Australia, MIROC-CHEM predicts almost no elevation in this region. For 2000s,
CICERO-OsloCTM2 still presents outliner data range compared with others and it would
not be used to calculate the unweighted mean value for the multi-ensemble.
Due to the availability of data, only one year’s data is used for NCAR-CAM3.5, which
might contributes to the uncertainty in unweighted mean results. Multi-model ensemble
is conducted for the output from all five models including GFDL-AM3, GISS-E2-R,
MIROC-CHEM, NCAR-CAM3.5 and NCAR-CAM5.1 for 2000s.
Figure 43,44,45 show the ensemble results from GFDL-AM3, MIROC-CHEM, NACRCAM3.5, NCAR-CAM5.1, GISS-E2-R for relative risk of COPD,LNC,LRI respectively in
2000s. The ensemble results indicate that the elevation of relative risk in East Asia
cannot be attributed to dust impact since dust concentration ensemble shows a near
background level of dust concentration in that region. The increased anthological
emission associated with industrial development and population growth in East Asia is
responsible for such elevation and increase between preindustrial times and current
years.

There is an obvious increase from 1850 to 2000 in East Asia due to the increasing
anthological emission while Saharan or Australia dust effect almost remain the same.
Increase is also observed in Arabian Peninsula, which is associated with increasing
dust load and a much smaller increase in secondary inorganic and carbonaceous
aerosol. (Boys et al., 2014) Multi-ensemble results are very important for depicting the
risk distribution in a more accurate way compared with single model. An obvious
elevation is observed in Central Australia from the ensemble results.
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Short-term health impact from Australia dust storm is proved in Merrifield’s study.
Australia dust storm has been found to be linked to daily hospital visits in Sydney in
Merrifield’s study. Asthma risk increased to 1.23 and respiratory risk increased to 1.20
for that period of time. (Merrifield et. al., 2013) Although chronic exposure is hard to
prove significant statistically in cohort studies but the model output does depicts the
elevation for chronic disease including cardiopulmonary disease and lower respiratory
infection for the populated regions including major cities and regional area. The dust
concentration ensemble output further indicates the dust peak in the central region of
Australia.
The ensemble output of dust concentration is presented in figure 46 for 2000s. The
elevation in dust concentration in Mediterranean and Saudi Arabic are very likely to be
responsible for the elevated relative risk from ensemble output.

4.6 POPULATION VARIANCE BETWEEN MODELS
Population Variance was calculated and plotted for 1850-1852 (figure 47) and 20002002 (figure 48) from four models (MIROC-CHEM, NCAR-CAM3.5, NCAR-CAM5.1 and
GISS-E2-R) for gird data. There is relatively a much higher variance for LRI than other
diseases between various models.
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Figure 47 The variance of the prediction of ambient PM2.5 concentration derived relative risk for cardiopulmonary
disease, lung cancer and lower respiratory infection between various models (MIROC-CHEM,NCAR-CAM3.5,NCARCAM5.1,GISS-E2-R) in 1850s. Higher variance value would indicate a more spread out status of various models. It is
worth noticing that lower respiratory infection relative risk has a much higher variance level than other disease
endpoints, which means that there would be more uncertainty coming from LRI relative risk output from model
difference.
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Figure 48 The variance of the prediction of ambient PM2.5 concentration derived relative risk for cardiopulmonary
disease, lung cancer and lower respiratory infection between various models (MIROC-CHEM,NCAR-CAM3.5,NCARCAM5.1,GISS-E2-R) in 2000s. Higher variance value would indicate a more spread out status of various models.
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4.7 GRID AVERAGE DATA FROM PRE-INDUSTRIAL TIME TO
PRESENT
By calculating the average value of relative risk from each time period, the tendency of
risk variation can be derived from the results to measure the exposure change globally
speaking. Figure 49 shows the grid average of the relative risk for cardiopulmonary
disease from 1850s (pre-industrial) to 2010s (current years). There is a general trend of
elevation in grid–averaged relative risk value from1850s to 2010s. The RR value peaks
in 1980s.
Figure 76, 77 in the appendix show the grid average of the relative risk for lung cancer
and lower respiratory infection respectively from 1850s (pre-industrial) to 2010s (current
years).
The variation in LRI relative risk value is relatively high while variation in COPD relative
risk value is low.

4.8 POPULATION NORMALIZED OUTPUT
Population normalization is conducted to measure the surface air pollution related to
human exposure. Such measure is used as in Apte’s study as a way to emphasize the
effect of population exposure. (Apte et al., 2015) Regions were divided to analyze the
regional distribution related to development level and geography.
The population normalized relative risk value for CIS regions peaks in January and
October. Developed countries peak in April. Northern Africa peaks in February and
November. Southern Asia peaks in February and December. Latin America and
Caribbean peak in January and October. Oceania peaks in September. Western Asia
peaks in February and December. Eastern Asia peaks in March. Developed countries
peak in April. Sub-Saharan peaks in March.
There is a sudden drop of normalized relative risk value for COPD in December for
Northern Africa. (See Table 1) RCP6.0 predicts a relatively higher concentration level
while RCP2.6 predicts lower level. There is an increase of predicted normalized surface
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PM2.5 concentration for developed countries while there is a general decrease trend for
other regions.
In SSP2 scenario, CIS regions is predicted with a much lower normalized PM2.5
concentration compared with SSP1 while there is not much different between two
scenarios for other regions. (See Table 2) Such result indicate that a moderately
sustainable population scenario would predict a lower level of population exposure in
CIS.
Table 3 shows the population normalized relative risk value for various regions under
emission scenarios including RCP2.6,6.0,8.5 and time periods including
2000,2030,2050. The population scenario utilized is SSP1 and the results describe the
regional risk distribution from the output of MIROC-CHEM model. For the same
population scenario and RCP scenario, MIROC-CHEM actually predicts a much lower
normalized PM2.5 concentration value level compared with GISS-E2-R.
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Figure 49 Grid averaged COPD relative risk value for GISS-E2-R from 1850s to 2010s. Grid average is a depiction of
how the relative risk level has developed globally since preindustrial times. There is a general increasing trend since
pre-industrial times.
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TABLE 1 POPULATION NORMALIZED PM2.5 CONCENTRATION FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 and RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE
RISK.
scenarios

GISS-E2-R
SSP1
2000

2030

2050

hist

RCP2.6

RCP4.5

RCP6.0

RCP8.5

RCP2.6

RCP4.5

RCP6.0

RCP8.5

CIS

9.64

8.841

9.219

9.152

9.01

8.716

8.756

8.872

8.77

developed countries

16.90

17.384

17.899

17.726

17.37

17.54

17.436

17.578

17.493

Sub-Saharan Africa

7.32

6.768

7.293

6.861

6.768

6.7

6.843

7.15

6.779

Eastern Asia

12.04

11.23

11.528

11.665

11.479

11.233

11.033

11.456

11.26

Latin America and the Caribbean

17.45

16.668

16.963

17.576

16.065

16.631

16.693

17.338

17.282

Northern Africa

11.99

13.22

12.902

13.03

13.07

13.196

13.003

12.861

12.938

Oceania

8.84

8.487

8.025

7.936

8.014

8.451

8.012

8.559

8.813

Southern Asia

6.85

6.331

5.999

6.137

5.908

6.288

5.355

5.971

5.884

South-Eastern Asia

8.15

7.669

7.506

8.674

8.425

7.708

6.603

8.584

8.56

Western Asia

13.48

13.001

13.63

13.345

13.12

12.92

12.955

13.332

12.794

regions
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TABLE 2 POPULATION NORMALIZED PM2.5 CONCENTRATION FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP2 AND DIFFERENT RCP
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 and RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE
RISK.
scenarios

GISS-E2-R
SSP2
2000
hist

2030
RCP2.6

RCP4.5

2050
RCP6.0

RCP8.5

RCP2.6

RCP4.5

RCP6.0

RCP8.5

regions
CIS

9.059

7.703

7.984

8.044

7.885

7.545

7.448

7.68

7.544

developed countries

16.896

17.401

17.92

17.745

17.389

17.547

17.486

17.62

17.55

Sub-Saharan Africa

7.3167

6.76

7.285

6.854

6.757

6.774

6.867

7.154

6.77

Eastern Asia

12.016

11.197

11.504

11.626

11.446

11.204

10.977

11.41

11.20

Latin America and the Caribbean

17.447

16.653

16.954

17.559

16.059

17.265

16.666

17.302

17.26

Northern Africa

13.055

13.223

12.9

13.027

13.069

12.929

12.994

12.85

12.93

8.836

8.483

8.02

7.93

8.008

8.806

8.004

8.554

8.806

Southern Asia

6.8832

6.334

5.98

6.132

5.883

5.851

5.315

5.927

5.851

South-Eastern Asia

8.8398

8.504

8.34

9.445

9.156

9.475

7.323

9.324

9.475

Western Asia

13.476

13

13.626

13.34

13.116

12.783

12.945

13.317

12.78

Oceania
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TABLE 3 POPULATION NORMALIZED PM2.5 CONCENTRATION FOR MIROC-CHEM MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP
SCENARIOS (RCP2.6, RCP6.0 and RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH POPULATION
SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE RISK.
region

MIROC-CEHM
SSP1
2000

2030

2050

hist

RCP2.6

RCP6.0

RCP8.5

RCP2.6

RCP6.0

RCP8.5

CIS

1.569

1.069

1.386

1.32

0.934

1.295

1.209

developed countries

7.256

7.909

7.962

8.837

8.219

7.121

9.717

Sub-Saharan Africa

1.073

1.082

1.131

1.077

1.015

1.069

1.146

Eastern Asia

3.973

2.606

3.052

2.342

2.109

2.421

2.053

Latin America and the Caribbean

5.102

5.954

5.877

6.139

4.884

6.608

6.00

Northern Africa

1.672

1.407

1.538

1.531

1.236

1.531

1.461

Oceania

1.927

2.078

1.898

1.772

1.941

1.924

2.121

Southern Asia

4.197

3.422

3.199

3.014

2.595

2.679

2.729

South-Eastern Asia

4.925

0.004

4.576

1.077

4.013

4.317

4.09

Western Asia

1.781

1.331

1.509

1.508

1.226

1.428

1.442
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TABLE 4 POPULATION NORMALIZED COPD RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE
RISK.
scenarios

GISS-E2-R
SSP1
2000

2030

2050

hist

RCP2.6

RCP4.5

RCP6.0

RCP8.5

RCP2.6

RCP4.5

RCP6.0

RCP8.5

CIS

1.0515

1.048

1.05

1.0496

1.049

1.0479

1.048

1.0485

1.048

developed countries

1.0777

1.079

1.081

1.0804

1.0794

1.0799

1.079

1.08

1.08

Sub-Saharan Africa

1.0425

1.04

1.042

1.0408

1.0404

1.0401

1.0408

1.0418

1.04

Eastern Asia

1.0609

1.058

1.059

1.0594

1.0587

1.0578

1.057

1.0586

1.058

Latin America and the Caribbean

1.0788

1.076

1.077

1.0791

1.074

1.076

1.0756

1.0784

1.078

Northern Africa

0.9962

1.065

1.064

1.0646

1.0647

1.0651

1.064

1.0639

1.064

Oceania

1.0485

1.047

1.045

1.045

1.0453

1.047

1.0453

1.0474

1.048

Southern Asia

1.0409

1.039

1.038

1.0381

1.0372

1.037

1.035

1.0374

1.037

South-Eastern Asia

1.0456

1.044

1.043

1.0476

1.0466

1.0439

1.04

1.0472

1.047

Western Asia

1.0662

1.064

1.067

1.0657

1.0648

1.064

1.0642

1.0656

1.064

regions

78

TABLE 5 POPULATION NORMALIZED COPD RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP2 AND DIFFERENT RCP
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE
RISK.
scenarios

GISS-E2-R
SSP2
2000

2030

2050

hist

RCP2.6

RCP4.5

RCP6.0

RCP8.5

RCP2.6

RCP4.5

RCP6.0

RCP8.5

CIS

1.049

1.044

1.045

1.045

1.0447

1.0434

1.043

1.044

1.043

developed countries

1.078

1.079

1.081

1.08

1.0794

1.0799

1.08

1.08

1.08

Sub-Saharan Africa

1.0425

1.040

1.042

1.041

1.0403

1.0404

1.041

1.042

1.04

Eastern Asia

1.0608

1.058

1.059

1.059

1.0586

1.0577

1.057

1.059

1.058

1.076

1.077

1.079

1.074

1.0777

1.075

1.078

1.078

regions

Latin America and the
Caribbean

1.0788

Northern Africa

1.0646

1.066

1.064

1.064

1.0647

1.0641

1.064

1.064

1.064

Oceania

1.0485

1.047

1.045

1.045

1.0453

1.0483

1.045

1.047

1.048

Southern Asia

1.041

1.039

1.037

1.038

1.0371

1.037

1.035

1.037

1.037

South-Eastern Asia

1.048

1.047

1.046

1.05

1.0494

1.0505

1.042

1.05

1.050

Western Asia

1.0662

1.064

1.067

1.066

1.0648

1.0635

1.064

1.0656

1.064
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Table 4 and table 5 show that the relative risk value for COPD from GISS-E2-R model
output with SSP2 has much lower value for CIS region than SSP1. The COPD risk
value with SSP2 for south-eastern Asia is much higher than that with SSP1. There is a
slight lowering trend from 2000 to 2050 with SSP2 dataset while the different between
different RCP scenarios is limited.
For CIS region, relative risk for LRI with SSP2 dataset has lower value than SSP1. The
different between SSP1 and SSP2 for relative risk of LRI for other regions is very
limited. (See Table 8&9) The LRI relative risk values for regions including CIS, SubSaharan Africa, Oceania, South-Eastern Asia are around 1, so the health risk of lower
respiratory infection for those regions from surface PM2.5 exposure is very limited.
The normalized PM2.5 data for CIS, northern Africa, Oceania, Sub-Saharan Africa, south
Asia regions with SSP3 is much lower than SSP1 and SSP2 under the same RCP
scenarios and models. While normalized concentration or risk value for eastern Asia,
east Asia and Latin America and the Caribbean are predicted with much higher values
with SSP3.(See Table 10)
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TABLE 6 POPULATION NORMALIZED LNC RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE
RISK.
scenarios

GISS-E2-R
SSP1
2000
hist

2030
RCP2.6

RCP4.5

2050

RCP6.0

RCP8.5

RCP2.6

RCP4.5

RCP6.0

RCP8.5

regions
CIS

1.0625

1.057

1.059

1.06

1.0586

1.0566

1.0573

1.0579

1.0571

developed countries

1.0994

1.103

1.11

1.1064

1.1038

1.1037

1.1065

1.1046

1.106

Sub-Saharan Africa

1.0501

1.046

1.047

1.0487

1.0437

1.0454

1.0455

1.0474

1.0422

1.046

1.069

1.07

1.074

1.0403

1.0688

1.0705

1.0727

1.0711

1.1

1.095

1.103

1.103

1.0985

1.0952

1.098

1.1013

1.1082

Northern Africa

1.0094

1.081

1.081

1.0821

1.083

1.0812

1.0816

1.0802

1.0802

Oceania

1.0554

1.055

1.051

1.0525

1.052

1.0552

1.0516

1.057

1.0576

1.046

1.042

1.0403

1.0418

1.0403

1.0421

1.0361

1.0409

1.0387

South-Eastern Asia

1.0538

1.048

1.05

1.0583

1.05256

1.0484

1.0445

1.0563

1.0498

Western Asia

1.0856

1.082

1.085

1.0848

1.0827

1.0812

1.081

1.0833

1.079

Eastern Asia
Latin America and the Caribbean

Southern Asia
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TABLE 7 POPULATION NORMALIZED LNC RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP2 AND DIFFERENT RCP
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE
RISK.
scenarios

GISS-E2-R
SSP2
2000
hist

2030
RCP2.6

RCP4.5

2050

RCP6.0

RCP8.5

RCP2.6

RCP4.5

RCP6.0

RCP8.5

regions
CIS

1.059

1.051

1.052

1.053

1.0518

developed countries

1.099

1.103

1.11

1.106

Sub-Saharan Africa

1.0501

1.046

1.047

Eastern Asia

1.0768

1.068

Latin America and the
Caribbean

1.05

1.05

1.051

1.05

1.104

1.1063

1.107

1.105

1.106

1.049

1.1044

1.0422

1.045

1.047

1.042

1.072

1.074

1.0708

1.0707

1.07

1.073

1.0707

1.095

1.103

1.103

1.0985

1.1081

1.1

1.101

1.108

1.1

Northern Africa

1.079

1.082

1.081

1.082

1.083

1.08

1.082

1.08

1.08

Oceania

1.055

1.055

1.051

1.052

1.052

1.0575

1.051

1.057

1.058

Southern Asia

1.046

1.042

1.04

1.042

1.04

1.0385

1.036

1.041

1.038

South-Eastern Asia

1.058

1.052

1.055

1.063

1.0568

1.0545

1.049

1.061

1.0545

1.0856

1.082

1.085

1.085

1.0827

1.0789

1.081

1.083

1.0789

Western Asia
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TABLE 8 POPULATION NORMALIZED LRI RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP1 AND DIFFERENT RCP
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE
RISK.
scenarios

GISS-E2-R
SSP1
2000
hist

2030
RCP2.6

RCP4.5

2050

RCP6.0

RCP8.5

RCP2.6

RCP4.5

RCP6.0

RCP8.5

regions
CIS
developed countries

0.9871
1.0836

0.975

0.981

0.9795

0.978

0.9737

0.9742

0.976

0.9744

1.09

1.096

1.0933

1.0897

1.0918

1.0896

1.093

1.0911

Sub-Saharan Africa

0.9535

0.946

0.953

0.947

0.946

0.9446

0.9473

0.951

0.9458

Eastern Asia

1.0221

1.011

1.015

1.0167

1.014

1.0107

1.0078

1.014

1.0109

1.077

1.079

1.0879

1.0694

1.077

1.0746

1.0853

1.0827

Latin America and the
Caribbean

1.0871

Northern Africa

0.9669

1.038

1.034

1.0358

1.0362

1.038

1.0351

1.0332

1.0342

Oceania

0.9759

0.971

0.964

0.9627

0.964

0.97

0.9639

0.9718

0.9753

Southern Asia

0.9475

0.94

0.935

0.9371

0.9339

0.939

0.9258

0.9346

0.9335

South-Eastern Asia

0.9651

0.958

0.956

0.9724

0.9687

0.959

0.9432

0.9709

0.9703

Western Asia

1.0417

1.035

1.044

1.04

1.0367

1.034

1.0343

1.04

1.032
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TABLE 9 POPULATION NORMALIZED LRI RELATIVE RISK FOR GISS-E2-R MODEL UNDER POPULATION SCENARIO SSP2 AND DIFFERENT RCP
SCENARIOS (RCP2.6, RCP4.5, RCP6.0 AND RCP8.5) FOR THE TIME PERIOD OF 2000S,2030S,2050S AS MEASURING THE EFFECT OF BOTH
POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE
RISK.
scenarios

GISS-E2-R
SSP2
2000
hist

2030
RCP2.6

RCP4.5

2050

RCP6.0

RCP8.5

RCP2.6

RCP4.5

RCP6.0

RCP8.5

regions
CIS

0.9788

0.959

0.963

0.964

0.962

0.9568

0.9554

0.9588

0.9568

developed countries

1.0836

1.09

1.096

1.094

1.09

1.092

1.09

1.0935

1.0917

Sub-Saharan Africa

0.9535

0.945

0.953

0.947

0.945

0.9457

0.947

0.951

0.9457

Eastern Asia

1.022

1.01

1.014

1.016

1.014

1.0101

1.007

1.0137

1.01

Latin America and the Caribbean

1.087

1.077

1.079

1.088

1.069

1.0825

1.074

1.0848

1.0824

Northern Africa

1.0359

1.039

1.034

1.036

1.036

1.0341

1.035

1.0331

1.034

Oceania

0.9758

0.97

0.964

0.963

0.964

0.9752

0.964

0.9717

0.9752

0.948

0.94

0.935

0.937

0.934

0.933

0.925

0.934

0.933

South-Eastern Asia

0.9749

0.97

0.967

0.983

0.979

0.9832

0.954

0.9814

0.9832

Western Asia

1.0417

1.035

1.044

1.04

1.037

1.0319

1.034

1.0395

1.0319

Southern Asia
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TABLE 10 POPULATION NORMALIZED PM2.5 CONCENTRATION, COPD RISK, LNC RISK, LRI RISK RESPECTIVELY FOR GISS-E2-R MODEL UNDER
POPULATION SCENARIO SSP3 FOR THE TIME PERIOD OF 2000S AS MEASURING THE EFFECT OF BOTH POPULATION SCENARIO AND
GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE RISK.
GISS-E2-R SSP3
Regions

2000
hist
PM2.5

COPD

LNC

LRI

CIS

7.984

1.045

1.052

0.963

DC

17.921

1.081

1.11

1.096

EA

11.504

1.059

1.072

1.014

LAC

16.954

1.077

1.103

1.079

NA

12.9

1.064

1.081

1.034

O

8.02

1.045

1.051

0.964

SA

5.979

1.037

1.04

0.935

SEA

8.34

1.046

1.055

0.967

SSA

7.285

1.042

1.047

0.953

WA

13.626

1.067

1.085

1.044
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TABLE 11 POPULATION NORMALIZED PM2.5 CONCENTRATION, COPD RISK, LNC RISK, LRI RISK RESPECTIVELY FOR GISS-E2-R MODEL UNDER
POPULATION SCENARIO SSP3 AND EMISSION SCENARIOS (RCP2.6,RCP4.5,RCP6.0,RCP8.5) FOR THE TIME PERIOD OF 2030S AS MEASURING THE
EFFECT OF BOTH POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION
NORMALIZED RELATIVE RISK.
GISS-E2-R SSP3
Regions

2030
RCP2.6

RCP4.5

RCP6.0

RCP8.5

PM2.5

COPD

LNC

LRI

PM2.5

COPD

LNC

LRI

PM2.5

COPD

LNC

LRI

PM2.5

COPD

LNC

LRI

CIS

7.43

1.043

1.049

0.955

7.68

1.044

1.05

0.959

7.79

1.044

1.052

0.96

7.62

1.044

1.05

0.958

DC

17.40

1.079

1.103

1.09

17.94

1.081

1.11

1.096

17.73

1.08

1.106

1.094

17.4

1.079

1.104

1.09

EA

11.22

1.058

1.069

1.01

11.52

1.059

1.072

1.015

11.66

1.059

1.074

1.017

11.47

1.059

1.071

1.01

LAC

16.61

1.076

1.095

1.077

16.92

1.077

1.103

1.079

17.5

1.079

1.103

1.087

16.04

1.074

1.098

1.069

NA

13.16

1.065

1.081

1.037

12.85

1.064

1.08

1.033

12.96

1.064

1.082

1.035

13.05

1.064

1.083

1.036

O

8.49

1.047

1.055

0.971

8.02

1.045

1.05

0.964

7.94

1.045

1.052

0.963

8.01

1.045

1.052

0.964

SA

6.31

1.039

1.042

0.939

5.95

1.037

1.04

0.935

6.12

1.038

1.042

0.937

5.89

1.037

1.04

0.934

SEA

7.73

1.044

1.048

0.959

7.58

1.043

1.05

0.957

8.74

1.048

1.059

0.973

8.5

1.047

1.053

0.97

SSA

6.84

1.041

1.046

0.946

6.5

0.92

0.924

0.842

6.9

1.041

1.049

0.948

6.031

0.918

0.921

0.835

WA

12.96

1.064

1.081

1.035

13.59

1.067

1.084

1.043

13.29

1.066

1.084

1.039

13.12

1.065

1.082

1.04
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TABLE 12 POPULATION NORMALIZED PM2.5 CONCENTRATION, COPD RISK, LNC RISK, LRI RISK RESPECTIVELY FOR GISS-E2-R MODEL UNDER
POPULATION SCENARIO SSP3 AND EMISSION SCENARIOS (RCP2.6,RCP4.5,RCP6.0,RCP8.5) FOR THE TIME PERIOD OF 2050S AS MEASURING THE
EFFECT OF BOTH POPULATION SCENARIO AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION
NORMALIZED RELATIVE RISK.
GISS-E2-R SSP3
Regions

2050
RCP2.6

RCP4.5

RCP6.0

RCP8.5

PM2.5

COPD

LNC

LRI

PM2.5

COPD

LNC

LRI

PM2.5

COPD

LNC

LRI

PM2.5

COPD

LNC

LRI

CIS

6.84

1.0406

1.0455

0.9466

6.96

1.041

1.047

0.948

7.235

1.042

1.048

0.952

7.089

1.042

1.047

0.95

DC

17.54

1.0799

1.1061

1.091

17.54

1.08

1.107

1.091

17.68

1.08

1.105

1.094

17.622

1.08

1.107

1.093

EA

11.01

1.0569

1.07

1.007

11

1.057

1.07

1.007

11.43

1.058

1.072

1.013

11.231

1.058

1.071

1.01

LAC

15.12

1.0706

1.089

1.0568

16.55

1.075

1.097

1.073

17.21

1.078

1.1

1.084

17.181

1.077

1.108

1.081

NA

12.63

1.063

1.079

1.03

12.95

1.064

1.081

1.034

12.82

1.064

1.08

1.033

12.891

1.064

1.08

1.033

O

7.69

1.0441

1.049

0.9595

8

1.045

1.051

0.964

8.56

1.047

1.057

0.972

8.812

1.048

1.058

0.975

SA

5.567

1.0358

1.038

0.9288

5.304

1.035

1.036

0.925

5.92

1.037

1.041

0.934

5.831

1.037

1.038

0.933

SEA

8.75

1.0477

1.057

0.9728

6.78

1.04

1.046

0.946

8.77

1.048

1.057

0.974

8.774

1.048

1.051

0.973

SSA

7.06

1.0415

1.046

0.9497

6.905

1.04

1.046

0.948

7.22

1.042

1.048

0.952

6.805

1.04

1.042

0.946

WA

12.77

1.0635

1.079

1.032

12.96

1.064

1.08

1.034

13.28

1.065

1.083

1.039

12.792

1.064

1.079

1.032
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Table 11 and table 12 depict population normalized PM2.5 concentration, COPD risk,
LNC risk, LRI risk for GISS-E2-R model under population scenario SSP3 and emission
scenarios (RCP2.6,RCP4.5,RCP6.0,RCP8.5) for the time period of 2030s and 2050s
respectively.
With SSP3 as the population scenario, RCP6.0 represents a higher level of normalized
value for regions including CIS, DC, EA, LAC, SA, SSA and WA.
From the GISS-E2-R and SSP3, it is shown that there is generally a decreasing trend of
population normalized PM2.5 concentration and related relative risk from 2000s to 2050s
for various scenarios.
Among various emission scenarios, RCP6.0 predicts the highest surface pollution level
in the future while RCP2.6 predicts the lowest. From 2000s to 2050s, the equivalent
carbon dioxide increase ranks from high to low as RCP8.5, RCP4.5, RCP6.0 and
RCP2.6. The reason for such distribution is due to the difference in radiative forcing
value settings. Population normalized concentration is more useful in predicting human
exposure derived health impact because the relative risk for each grid would be
substantially lower if the population for such grid is extremely low. Such calculation
would avoid situation of the too high or too low relative risk in regions with low
population causing effect on the overall relative risk or concentration.
For regional distribution, developed countries and Latin America have the highest
population normalized concentration and associated relative risk with western Asia and
Southern Asia come next.
Surface PM2.5 exposure has a much lower effect upon chronic lower respiratory infection
while has a much higher effect upon LNC and COPD. In Jassen’s study (Janssen et al.,
2011), black carbon is used as additional predictor for health impact since black carbon
is more toxic than the other component in PM2.5. In their study, assumption was made
about that black carbon is 5 times more toxic than the other components so black
carbon mass is multiplied by 5 to adjust the health impact related PM2.5 concentration. It
was concluded black carbon is a valuable tool to predict health impact.
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For further optimizing the output for health risk, black carbon mass adjusted PM2.5 mass
concentration and derived relative risks are calculated for NACR-CAM5.1 model output
for the three year average of surface PM2.5 concentration of 2000 to 2002.
The original calculation function for PM2.5 mass concentration:
PM2.5=BC + OA + SO4 + SOA + NO3 + NH4 + 0.25*SS + 0.1*Dust
The adjusted calculation function for PM2.5 mass concentration:
PM2.5=5*BC + OA + SO4 + SOA + NO3 + NH4 + 0.25*SS + 0.1*Dust
The point in adjusting relative risk with black carbon concentration is to discover
whether it should be necessary to consider the effect from black carbon since IER
model or other C-R functions may only take the mass concentration of particulate matter
into consideration instead of assessing the health impact regarding the toxicity of all the
components.
Different population scenarios might have slight impact on population normalized fine
particle surface concentration but the resulted relative risk change is very trivial.
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TABLE 13 POPULATION NORMALIZED PM2.5 CONCENTRATION, COPD RISK, LNC RISK, LRI RISK RESPECTIVELY FOR NCAR-CAM5.1 MODEL UNDER
POPULATION SCENARIO SSP1,SSP2,SSP3 FOR THE TIME PERIOD OF 2000S AS MEASURING THE EFFECT OF BOTH POPULATION SCENARIO AND
GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION NORMALIZED RELATIVE RISK.
region

PM2.5

NCAR-CAM 5.1 SSP1

NCAR-CAM 5.1 SSP2

NCAR-CAM 5.1 SSP3

2000

2000

2000

COPD

LNC

LRI

PM2.5

COPD

LNC

LRI

PM2.5

COPD

LNC

LRI

CIS

4.018

1.0299

1.0294

0.9064

3.954

1.03

1.029

0.9054

3.924

1.03

1.0288

0.905

developed countries

16.75

1.0698

1.091

1.0476

16.75

1.07

1.091

1.0476

16.75

1.07

1.091

1.048

Sub-Saharan Africa

7.489

1.0433

1.0484

0.9566

7.489

1.043

1.048

0.9565

7.581

1.044

1.0488

0.958

6.2

1.0384

1.0417

0.9384

6.238

1.038

1.0419

0.939

6.2

1.038

1.04169

0.938

10.712

1.0554

1.0666

1.001

10.712

1.055

1.0666

1.001

10.71

1.055

1.0666

1.001

Northern Africa

6.409

1.0392

1.0435

0.9415

6.409

1.039

1.0435

0.9415

6.382

1.039

1.0433

0.941

Oceania

9.178

1.0499

1.0584

0.9811

9.177

1.05

1.058

0.9811

9.178

1.04989

1.0584

0.981

Southern Asia

7.244

1.0425

1.0476

0.9534

7.245

1.042

1.0477

0.9534

7.244

1.0425

1.0476

0.953

14.166

1.0682

1.0877

1.049

13.573

1.066

1.0846

1.041

14.166

1.0682

1.0877

1.049

6.302

1.0388

1.0426

0.9399

6.302

1.0388

1.0426

0.9399

6.378

1.0391

1.043

0.941

Eastern Asia
Latin America and the
Caribbean

South-Eastern Asia
Western Asia
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TABLE 14 POPULATION NORMALIZED BLACK CARBON ADJUSTED NEW PM2.5 CONCENTRATION, COPD
RISK, LNC RISK, LRI RISK RESPECTIVELY FOR NCAR-CAM5.1 MODEL UNDER POPULATION SCENARIO
SSP1 FOR THE TIME PERIOD OF 2000S AS MEASURING THE EFFECT OF BOTH POPULATION SCENARIO
AND GREENHOUSE GAS EMISSION SCENARIOS UPON REGIONAL DISTRIBUTION OF POPULATION
NORMALIZED RELATIVE RISK.
region

NCAR-CAM 5.1 SSP1
2000
NEWPM2.5

RRCOPD

RRLNC

RRLRI

CIS

4.11

1.0302

1.0300

0.9078

developed countries

17.03

1.0708

1.0925

1.0511

Sub-Saharan Africa

7.52

1.0434

1.0485

0.957

Eastern Asia

6.33

1.0389

1.0425

0.9403

Latin America and the Caribbean

11.8

1.0593

1.0728

1.0159

Northern Africa

6.437

1.0394

1.0437

0.942

Oceania

9.41

1.0508

1.0598

0.9844

Southern Asia

7.737

1.0444

1.0505

0.9605

South-Eastern Asia

14.62

1.0699

1.0902

1.055

Western Asia

6.345

1.0390

1.0428

0.9405

From table 13 and table 14, the comparison between original PM2.5 and derived relative
risk and black carbon adjusted value is made to test whether the approach of black
carbon adjustment of relative risk would be necessary to alter the current methodology
of only taking mass concentration into consideration when measuring health impact. If
the difference between non-adjustment and adjustment is big enough, the toxicity of
black carbon should also be regarded when calculating relative risk.
The increase in COPD relative risk for various regions from SSP1 scenarios:
CIS:0.03%; DC:0.09%; SSA:0.01%; EA:0.05%; LAC:0.37%; NA:0.02%; O:0.086%;
SA:0.2%; SEA:0.16%, WA:0.02%
From the increase in black carbon adjusted relative risk for COPD disease, it is shown
that Latin America and the Caribbean and southern Asia would be facing relatively
higher COPD exposure risk with the black carbon influence while there is not much
black carbon COPD risk in Sub-Saharan Africa, western Asia or CIS.
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The increase in LNC relative risk for various regions from SSP1 scenarios:
CIS:0.06%; DC:0.14%; SSA:0.01%; EA:0.39%; LAC:0.58%; NA:0.02%; O:0.13%;
SA:0.28%; SEA:0.23%, WA:0.02%
From the increase in black carbon adjusted relative risk for LNC disease, it is shown
that Latin America and the Caribbean and Eastern Asia would be facing relatively higher
LNC exposure risk with the black carbon influence while there is not much black carbon
LNC risk in Sub-Saharan Africa, western Asia or Northern Africa. It is worth noting that
there is large increase in LNC risk compared with COPD risk for eastern Asia. LNC
derived relative risk might be much more sensitive for black carbon compared with
COPD or LRI.
The increase in LRI relative risk for various regions from SSP1 scenarios:
CIS:0.15%; DC:0.33%; SSA:0.04%; EA:0.2%; LAC:1.49%; NA:0.05%; O:0.34%;
SA:0.74%; SEA:0.57%, WA:0.06%
From the increase in black carbon adjusted relative risk for LRI disease, it is shown that
southern Asia and South-eastern Asia would be facing relatively higher LRI exposure
risk with the black carbon influence while there is not much black carbon LRI risk in
South-eastern Africa or western Asia. There is an extremely high increase in the
relative risk for LAC. LAC region is more sensitive to black carbon surface pollution
compared with other regions.
Table 15 and 16 depict the COPD mortality from GISS-E2-R output under population
scenario SSP1, SSP2 and SSP3 for the time period of 2000s and 2050s respectively.
For lower respiratory infection premature mortality, the difference is much higher and
should take black carbon toxicity into consideration for higher accuracy since lower
respiratory infection risk would be higher than other two diseases when PM2.5 exceeds
20.2 µg/m3.
Mortality in eastern Asia is Southern Asia are highest among all regions in current days
or near future. There is an obvious increase in mortality in Southern Asia while slightly
decreased mortality in Eastern Asia. There is a very slight decrease in the population
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average risk value so the relatively large population base in eastern and southern Asia
might contribute to the mortality increase and the dominant mortality among all regions.
From the population information from table 17 and 18, it can be said that population
variance for Sub-Saharan Africa is hugely varied among different population scenarios.
A highly-fragmented scenario would predict a much higher population in Sub-Saharan
region in the future especially as Sub-Saharan would have higher population amount
than eastern Asia in SSP3. There is a substantial increase in Sub-Saharan Africa from
2000 to 2030. The population normalized relative risk for COPD disease is not largely
changed with the value at 1.04, so the population exposure to Saharan dust would
increase due to population growth alone.
It is calculate that there is 460,548,477(unit: person) estimated COPD mortality under
SSP1, SSP2, SSP3 scenarios respectively at 2000 and 520,637,581(unit: person)
estimated COPD mortality under SSP1, SSP2, SSP3 scenarios respectively at 2030
under emission scenario RCP2.6.

TABLE 15 COPD MORTALITY FROM GISS-E2-R OUTPUT UNDER POPULATION SCENARIO SSP1, SSP2 and
SSP3 FOR THE TIME PERIOD OF 2000S
region

COPD mortality GISS-E2-R 2000
Unit: person per year
SSP1

SSP2

SSP3

CIS

14.67

15.17

14.42

developed countries

33.00

33.00

33.00

Sub-Saharan Africa

26.25

26.25

37.33

230.50

282.75

230.50

20.17

20.17

20.17

Northern Africa

6.67

6.67

9.17

Oceania

0.42

0.42

0.42

Southern Asia

95.08

124.92

95.08

South-Eastern Asia

24.67

30.17

24.67

8.50

8.50

11.75

Eastern Asia
Latin America and the Caribbean

Western Asia
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TABLE 16 COPD MORTALITY FROM GISS-E2-R OUTPUT UNDER POPULATION SCENARIO SSP1, SSP2 AND
SSP3 FOR THE TIME PERIOD OF 2030S UNDER THE RCP2.6 EMISSION SCENARIO
region

COPD mortality GISS-E2-R
RCP2.6 2030
Unit: person per year
SSP1

SSP2

SSP3

CIS

14.17

15.17

14.67

developed countries

38.58

38.25

36.17

Sub-Saharan Africa

48.08

50.92

76.50

Eastern Asia

219.75

275.08

225.17

Caribbean

24.50

25.42

26.75

Northern Africa

8.92

9.25

13.42

Oceania

0.58

0.58

0.67

Southern Asia

123.33

172.92

135.83

South-Eastern Asia

27.08

34.50

29.08

Western Asia

14.58

15.33

22.58

Latin America and the

TABLE 17 POPULATION FOR VARIOUS REGIONS IN 2000 PREDICTED BY POPULATION SCENARIOS
INCLUDING SSP1, SSP2 AND SSP3
region

population 2000
Unit: million
SSP1

SSP2

SSP3

CIS

236.17

255.25

246

developed countries

798.56

798.56

798.56

Sub-Saharan Africa

443.73

443.73

619

1049.39

1288.95

1049.39

374.85

374.85

374.85

89.8

89.8

123.68

4.4

4.4

4.4

1048.04

1373.02

1048.4

408.94

472.92

408.94

99.32

99.32

138.07

Eastern Asia
Latin America and the
Caribbean
Northern Africa
Oceania
Southern Asia
South-Eastern Asia
Western Asia
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TABLE 18 POPULATION FOR VARIOUS REGIONS IN 2030 PREDICTED BY POPULATION SCENARIOS
INCLUDING SSP1, SSP2 AND SSP3
region

population 2030
Unit: million
SSP1

SSP2

SSP3

CIS

243.43

285.96

283.18

developed countries

912.29

904.42

854.74

Sub-Saharan Africa

854.88

906.66

1351.49

1053.63

1321.93

1080.27

Caribbean

470.42

489

516.06

Northern Africa

118.66

123.28

179.24

6.54

6.90

7.19

1433.07

2008.63

1580.92

South-Eastern Asia

468.57

556.26

500.48

Western Asia

175.68

183.88

271.93

Eastern Asia
Latin America and the

Oceania
Southern Asia
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CHAPTER FIVE
CONCLUSION AND RECOMMENDATIONS

This study illustrates the continuous data from pre-industrial times and the future.
Integrated exposure–response (IER) functions are used rather than concentrationresponse functions in light of global mortality assessment to reduce the uncertainty
derived from health impact assessment function. Black carbon adjusted PM2.5
concentration is also applied to the health risk analysis. There is comparison between
various models, Representative Concentration Pathways and Socioeconomic pathways
scenarios to assess the impact of various scenarios.
For model comparison, NCAR-CAM3.5 has much lower prediction than other models
and the population-normalized value are much lower for MIROC-CHEM model than the
others. Multi-model ensemble is conducted to integrate the output from various models.
Ensemble results show that there is obvious increase from 1850 to 2000 in East Asia
and Arabian Peninsula. Variation related to various emission, population scenarios and
regional distribution are extensively discussed in this paper. Seasonal and time series of
relative risk variation are calculated and discussed in this paper as well.
In further related study, it would be interesting to see into the mortality variation with
more accurate baseline mortality data since the current available studies use country
level baseline mortality data instead of state or county level, which can be problematic
for the spatial analysis for large countries since the spatial distribution is going to be the
same over all a large terrain. Persistent peak of PM2.5 concentration and relative risk in
northern Africa regions might be attributed to the Saharan dust storm contribution,
which is also consistent with ensemble dust concentration output. Australia dust storm
also contributes to the elevation of relative risk. Eastern and south-eastern Asia would
be dominant in mortality compared with other regions.
There is a high increase (1.49%) in the lower respiratory infection relative risk for Latin
America and Caribbean region. it might be reasonable to take the black carbon toxicity
into consideration when addressing COPD mortality.
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Population normalized COPD premature mortality is calculated and compared in this
paper. There is 460,548,477 (unit: person) estimated COPD mortality under SSP1,
SSP2, SSP3 scenarios respectively at 2000 and 520,637,581 (unit: person) at 2030
under the emission scenario RCP2.6. The population exposure to Saharan dust would
increase due to population growth alone. The relatively large population base in eastern
and southern Asia might contribute to the mortality increase and the dominant mortality
of Asia among all regions.
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Figure 50 Global relative risk for lung cancer from January to June of the three year average data from 1850 to 1852
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude.
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function
from IER model for LNC disease endpoint.
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Figure 51 Global relative risk for lung cancer from July to December of the three year average data from 1850 to
1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentrationrisk function from IER model for LNC disease endpoint.
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Figure 52 Global relative risk for lower respiratory infection disease from January to June of the three year average
data from 1850 to 1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated
risk function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal
axes indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 53 Global relative risk for cardiopulmonary disease from July to December of the three year average data from
1850 to 1852 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 54 Global relative risk for cardiopulmonary disease from January to June of the three year average data from
1860 to 1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.
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Figure 55 Global relative risk for cardiopulmonary disease from July to December of the three year average data from
1860 to 1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.
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Figure 56 Global relative risk for lung cancer from January to June of the three year average data from 1860 to 1862
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude.
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function
from IER model for LNC disease endpoint.

112

Figure 57 Global relative risk for lung cancer from July to December of the three year average data from 1860 to
1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentrationrisk function from IER model for LNC disease endpoint.
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Figure 58 Global relative risk for lower respiratory infection disease from January to June of the three year average
data from 1860 to 1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated
risk function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal
axes indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 59 Global relative risk for lower respiratory infection disease from July to December of the three year average
data from 1860 to 1862 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated
risk function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal
axes indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 60 Global relative risk for cardiopulmonary disease from January to June of the three year average data from
2000 to 2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.
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Figure 61 Global relative risk for cardiopulmonary disease from July to December of the three year average data from
2000 to 2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.

117

Figure 62 Global relative risk for lung cancer from January to June of the three year average data from 2000 to 2002
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude.
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function
from IER model for LNC disease endpoint.
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Figure 63 Global relative risk for lung cancer from July to December of the three year average data from 2000 to
2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentrationrisk function from IER model for LNC disease endpoint.
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Figure 64 Global relative risk for lower respiratory infection from January to June of the three year average data from
2000 to 2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 65 Global relative risk for lower respiratory infection from July to December of the three year average data
from 2000 to 2002 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 66 Global relative risk for cardiopulmonary disease from January to June of the three year average data from
2030 to 2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.
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Figure 67 Global relative risk for cardiopulmonary disease from July to December of the three year average data from
2030 to 2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for COPD disease endpoint.
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Figure 68 Global relative risk for lung cancer from January to June of the three year average data from 2030 to 2032
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude.
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function
from IER model for LNC disease endpoint.
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Figure 69 Global relative risk for lung cancer from July to December of the three year average data from 2030 to
2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentrationrisk function from IER model for LNC disease endpoint.
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Figure 70 Global relative risk for lower respiratory infection from January to June of the three year average data from
2030 to 2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 71 Global relative risk for lower respiratory infection from July to December of the three year average data
from 2030 to 2032 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 72 Global relative risk for lung cancer from January to June of the three year average data from 2050 to 2052
with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function developed
for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate longitude.
The map plot indicate the monthly level of relative risk over a global terrain by applying the concentration-risk function
from IER model for LNC disease endpoint.
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Figure 73 Global relative risk for lung cancer from July to December of the three year average data from 2050 to
2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk function
developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes indicate
longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the concentrationrisk function from IER model for LNC disease endpoint.
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Figure 74 Global relative risk for lower respiratory infection from January to June of the three year average data from
2050 to 2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 75 Global relative risk for lower respiratory infection from July to December of the three year average data
from 2050 to 2052 with the ambient PM2.5 concentration output from GISS-E2-R model based on the integrated risk
function developed for GBD(Burnett et al., 2014b) for each figure, vertical axes indicate latitude and horizontal axes
indicate longitude. The map plot indicate the monthly level of relative risk over a global terrain by applying the
concentration-risk function from IER model for LRI disease endpoint.
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Figure 76 Grid averaged LNC relative risk value for GISS-E2-R from 1850s to 2010s. Grid average is a depiction of
how the relative risk level has developed globally since preindustrial times. There is a general increasing trend since
pre-industrial times.
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Figure 77 Grid averaged LRI relative risk value for GISS-E2-R from 1850s to 2010s. Grid average is a depiction of
how the relative risk level has developed globally since preindustrial times. There is a general increasing trend since
pre-industrial times.
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EPA

environmental protection agency

GBD

global burden of disease

IHD

ischemic heart disease

BenMAP-CE

Environmental Benefits Mapping and Analysis Program - Community Edition

C-R

concentration-response

ACCMIP

Atmospheric Chemistry and Climate Model Intercomparison Project

PM2.5

particle matter with aerodynamic diameter less than 2.5 micrometer

PM10

particle matter with aerodynamic diameter less than 10 micrometer

PM10-2.5

particle matter with aerodynamic diameter between 2.5 and 10 micrometer

EC

elemental carbon

OC

organic carbon

CRFs

concentration-response functions

IER

integrated exposure-response

COPD

chronic obstructive pulmonary disease

YLDs

Years lived with disability

RR

relative risk

SAT

Systematic Approach to Training

WHO

World Health Organization

AOD

aerosol optical depth

BC

black carbon

OA

organic aerosol

SOA

secondary organic aerosol

SS

sea slat

SSP

Shared Socio-economic Pathways

LRI

lower respiratory infection

LNC

lung cancer

DC

developed countries

CIS

Caucasus and Central Asia

NA

Northern Africa

LAC

Latin America and the Carribbean

EA

Eastern Asia

SA

Southern Asia

SEA

South-eastern Asia

WA

Western Asia

O

Oceania
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